STAAR Surgical Co
NASDAQ:STAA

Watchlist Manager
STAAR Surgical Co Logo
STAAR Surgical Co
NASDAQ:STAA
Watchlist
Price: 26.68 USD 0.19% Market Closed
Market Cap: 1.3B USD
Have any thoughts about
STAAR Surgical Co?
Write Note

STAAR Surgical Co
Total Liabilities & Equity

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

STAAR Surgical Co
Total Liabilities & Equity Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Liabilities & Equity CAGR 3Y CAGR 5Y CAGR 10Y
STAAR Surgical Co
NASDAQ:STAA
Total Liabilities & Equity
$537.6m
CAGR 3-Years
18%
CAGR 5-Years
23%
CAGR 10-Years
24%
Haemonetics Corp
NYSE:HAE
Total Liabilities & Equity
$2.5B
CAGR 3-Years
12%
CAGR 5-Years
16%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Total Liabilities & Equity
$4.3B
CAGR 3-Years
33%
CAGR 5-Years
21%
CAGR 10-Years
23%
Align Technology Inc
NASDAQ:ALGN
Total Liabilities & Equity
$6.4B
CAGR 3-Years
4%
CAGR 5-Years
22%
CAGR 10-Years
21%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Liabilities & Equity
$2B
CAGR 3-Years
34%
CAGR 5-Years
38%
CAGR 10-Years
23%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Liabilities & Equity
$2.4B
CAGR 3-Years
13%
CAGR 5-Years
6%
CAGR 10-Years
12%
No Stocks Found

STAAR Surgical Co
Glance View

Market Cap
1.3B USD
Industry
Health Care

STAAR Surgical Co. engages in the development, manufacture, production, marketing, and sale of implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The company is headquartered in Lake Forest, California and currently employs 692 full-time employees. The company is a manufacturer of lenses used worldwide in corrective or refractive surgery. The company sells its products in approximately 75 countries, with direct distribution in Japan, Germany, Spain, the United States, Canada, the United Kingdom and Singapore, with a combination of direct distribution and independent distribution in China, Korea, India, France, Benelux and Italy. Its manufacturing facility in Monrovia, California, makes the Visian implantable Collamer lens product family, including the EVO Visian ICL, preloaded silicone cataract intraocular lenses and injector systems. Its manufacturing facility in Brugg, Switzerland, operates an administrative, distribution and operational through its subsidiary, STAAR Surgical AG. The company operates administrative and distribution facilities in Japan through its subsidiary, STAAR Japan Inc.

STAA Intrinsic Value
22.19 USD
Overvaluation 17%
Intrinsic Value
Price

See Also

What is STAAR Surgical Co's Total Liabilities & Equity?
Total Liabilities & Equity
537.6m USD

Based on the financial report for Sep 27, 2024, STAAR Surgical Co's Total Liabilities & Equity amounts to 537.6m USD.

What is STAAR Surgical Co's Total Liabilities & Equity growth rate?
Total Liabilities & Equity CAGR 10Y
24%

Over the last year, the Total Liabilities & Equity growth was 14%. The average annual Total Liabilities & Equity growth rates for STAAR Surgical Co have been 18% over the past three years , 23% over the past five years , and 24% over the past ten years .

Back to Top